Article Figures & Data
Tables
- Table 1
Comparison of Baseline Values and Intermediate and Long-Term Changes in Clinical Outcome Measures in Intervention and Control Practice Patients
Control Practice (n = 359 Patients) Intervention Practice (n = 368 Patients) Clinical Parameters Baseline 18 Mo 36 Mo Baseline 18 Mo 36 Mo HbA1c, mean (SD), % 7.9 (2.2) 7.7 (1.9) 7.8 (2.0) 7.9 (2.1) 7.4 (1.6)a 7.4 (1.9)b ≤7.5 %, No. (%) 134 (56) 170 (60) 165 (59) 164 (55) 189 (66) 146 (68)c >7.5%, No. (%) 106 (44) 114 (40) 117 (41) 132 (45) 96 (34) 69 (32)c Systolic/diastolic blood pressure, mean 138 (18)/ 139 (16)/ 140 (17)/ 135 (16)/ 135 (14)/ 135 (16)/ (SD), mm Hg 81 (10) 80 (9) 79 (10) 79 (8) 78 (9) 78 (9) ≤40 mm Hg, No. (%) 208 (64) 198 (59) 178 (57) 257 (71) 222 (69)c 171 (69)c >140 mm Hg, No. (%) 116 (36) 140 (41) 134 (43) 107 (29) 101 (31)c 76 (31)c LDL cholesterol, mean (SD), mg/dL 101 (36) 99 (38) 97 (32) 105 (33) 95 (32) 99 (36)a ≤100 mg/dL, No. (%) 64 (52) 141 (57) 136 (59) 94 (46) 128 (61) 91 (57) >100 mg/dL, No. (%) 60 (48) 106 (43) 94 (41) 109 (54) 81 (39) 68 (43) HDL cholesterol, mean (SD), mg/dL 50 (13.3) 51 (13.4) 50 (13.3) 50 (12.7) 50 (13.6) 52 (13.9)a Total cholesterol, mean (SD), mg/dL 176 (39.7) 177 (42.5) 170 (38.1) 182 (38.1) 171 (37.7) 176 (39.1) - Table 2
Multivariate Model of Change in Hemoglobin A1c Level From Baseline to Final (Median 3.3 Years) Follow-up
Multivariate Linear Model Mean Change Multivariate Logistic Regression Model Change in Percentage With HbA1c≤7.5% Variable Model Parameter (SE) EffectP Value OR 95% CI Age 0.022 (0.006) <.001 1.041 1.007–1.075 Sex 0.18 4 (0.13 8) NS 0.804 0.356–1.818 Duration of diabetes −0.026 (0.010) .009 0.998 0.955–1.043 No. of visits per year 0.008 (0.029) NS 1.080 0.898–1.30 Baseline HbA1c level 0.606 (0.030) <.001 0.417 0.308–0.564 Intervention vs control clinic effecta .005 0.393 0.156–0.988 -
HbA1c = glycated hemoglobin; NS = nonsignificant; OR = odds ratio; SE =standard error.
-
↵a Fv1,v6 = 17.97.
-
Additional Files
The Article in Brief
Improved Outcomes in Diabetes Care for Rural African Americans
Paul Bray , and colleagues
Background Rural, low-income African American patients with diabetes traditionally have poorer clinical outcomes and limited access to state-of-the-art diabetes care. This study tests the effectiveness of a model of redesigned care on intermediate and long-term glycemic, blood pressure, and lipid levels for African American primary care patients with type 2 diabetes.
What This Study Found Redesigning diabetes care to incorporate interprofessional care management results in significantly improved glycemic control among rural, low-income African-American patients. Analyzing data on 727 diabetic patients at 3 rural primary care practices, researchers found patients in the intervention group who received point-of-care education, coaching, and medication intensification from a care management team comprised of a nurse, pharmacist, and dietician had significantly greater reduction in mean hemoglobin A1c levels than those receiving usual care at the 18-month and 36-month follow-ups . Moreover, a significantly greater percentage of patients in the intervention practices achieved a hemoglobin A1c value of less than 7.5 percent at the final assessments, and the proportion achieving a systolic blood pressure of less than 140 mm Hg was also substantially greater in the intervention group.
Implications
- The findings suggest that a portion of chronic diabetes management can be accomplished with an interprofessional team, potentially making clinicians more available for acute problems.